Paper414751
Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system.
Bigger CA and 2 others. Biochem Biophys Res Commun, 1978. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system. Papers, record 414751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/414751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 9,10-Dimethyl-1,2-benzanthracene | Major topic |
| Benz(a)Anthracenes | Major topic |
| DNA | Major topic |
| Microsomes, Liver | Major topic |
| Skin | Major topic |
| Animals | |
| Cells, Cultured | |
| Epoxy Compounds | |
| Female | |
| Mice | |
| Rats |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23994691 | The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. | Mol Aspects Med | 2014 | https://conductscience.org/library/papers/23994691 | PubMed |
| 7338531 | Polycyclic aromatic hydrocarbons and possible metabolites: convertogenic activity in yeast and tumor initiating activity in mouse skin. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7338531 | PubMed |
| 6989387 | Procedures for screening chemicals for carcinogenicity. | Br J Ind Med | 1980 | https://conductscience.org/library/papers/6989387 | PubMed |
| 6630287 | Carcinogenicity study in mice on pildralazine, a hydralazinelike antihypertensive compound. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6630287 | PubMed |
| 6500598 | Species specificity affects the choice of S9 preparations for use in the hamster embryo cell transformation system. | In Vitro | 1984 | https://conductscience.org/library/papers/6500598 | PubMed |
| 6337827 | Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs. | Environ Health Perspect | 1983 | https://conductscience.org/library/papers/6337827 | PubMed |
| 728339 | Thiophene analogues of the carcinogens benzidine and 4-aminobiphenyl: evaluation in vitro. | Br J Cancer | 1978 | https://conductscience.org/library/papers/728339 | PubMed |
| 511205 | Culture of adult rat lung cells: benzo(a)pyrene metabolism and mutagenesis. | In Vitro | 1979 | https://conductscience.org/library/papers/511205 | PubMed |
| 444395 | Biological activities of dihydrodiols derived from two polycyclic hydrocarbons in rodent test systems. | Br J Cancer | 1979 | https://conductscience.org/library/papers/444395 | PubMed |
| 106395 | Identification of 7,12-dimethylbenz[a]anthracene metabolites that lead to mutagenesis in mammalian cells. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/106395 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/414751
GET https://conductscience.org/api/papers/v1/414751/authors